Form 8-K - Current report:
SEC Accession No. 0001628280-24-038941
Filing Date
2024-08-30
Accepted
2024-08-30 13:47:17
Documents
15
Period of Report
2024-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20240826.htm   iXBRL 8-K 37980
2 EX-10.116 alt5sigmacorporationpetert.htm EX-10.116 178494
3 EX-99.1 alt5pressreleaseceoappoint.htm EX-99.1 13867
  Complete submission text file 0001628280-24-038941.txt   404704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20240826.xsd EX-101.SCH 1929
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20240826_lab.xml EX-101.LAB 23913
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20240826_pre.xml EX-101.PRE 13664
17 EXTRACTED XBRL INSTANCE DOCUMENT jan-20240826_htm.xml XML 2968
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241268759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)